Published in
Springer, Clinical and Experimental Medicine, 4(20), p. 587-600, 2020
DOI: 10.1007/s10238-020-00636-1
Links
Tools
LncPRYP4-3 serves as a novel diagnostic biomarker for dissecting subtypes of metabolic associated fatty liver disease by targeting RPS4Y2
Journal article published in 2020 by
Hongju Yang,
Qian Li,
Leisheng Zhang 
,
Mei Zhu,
Jie Niu,
Fenglin Xue,
Lihong Yang,
Qiu Qu,
Yaling Lao,
Zheng Ding,
Changyan Xiao,
Kunhua Wang
,
Mei Zhu,
Jie Niu,
Fenglin Xue,
Lihong Yang,
Qiu Qu,
Yaling Lao,
Zheng Ding,
Changyan Xiao,
Kunhua Wang
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 